Eric Venker, President & COO at Roivant Sciences Ltd. (ROIV), sold 210,945 shares at $10.22 ($2.2M) on 2025-04-21, disclosed to the SEC on 2025-04-22.
Scheduled sale ($2.2M) by President & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.15 | 10,945 | $111K | 5.2% |
| 2 | $10.22 | 100,000 | $1.0M | 47.4% |
| 3 | $10.22 | 100,000 | $1.0M | 47.4% |
| Total | $10.22 avg | 210,945 | $2.2M | 100% |
| Filing → |
| ROIV | SELL | 2026-09-01 | $7.2M | — | Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| IMVT | SELL | 2026-07-06 | $119K | — | Filing → |